Tata Trusts to fund innovations, technologies to combat TB and malaria
For the first time an Indian philanthropic organisation will be funding science to combat infectious diseases. The India Health Fund
Read MoreFor the first time an Indian philanthropic organisation will be funding science to combat infectious diseases. The India Health Fund
Read MoreIn a Phase III trial, delamanid drug was found to be safe but the cure rate and mortality rate were
Read MoreStopping antibiotics half way through the course, when a patient feels better, may not guarantee cure of the infection. A
Read MoreThe RNTCP guidelines on contact screening are heeded mostly in the breach. About 5,500 of over 76,000 children tested in
Read MoreCurcumin, the basic ingredient of turmeric, when administered in a nanoparticle formulation has several favourable properties in the treatment of
Read MoreIn 2015, India accounted for nearly 2.8 million (27%) of the 10.4 million new tuberculosis (TB) cases in the world,
Read MoreA cheaper, locally developed molecular diagnostic test, Truenat MTB, for drug-sensitive and rifampicin-resistant TB is entering the final leg of
Read MoreA team of Indian researchers has been able to achieve 100-fold reduction in TB bacterial load in lungs of mice
Read MoreNearly two months after the Health Ministry set a highly ambitious target of working towards elimination of tuberculosis by 2025, a
Read MoreThat vitamin C, an anti-oxidant agent, boosts and strengthens immunity is well known. Its ability to speed-up recovery from tuberculosis
Read MoreScientists at the Indian Institute of Science (IISc) Bengaluru have developed two new, potent molecules that can severely impact the
Read MoreAt the end of 50 years of tuberculosis control activities, the disease remains a major health challenge in India. As
Read MoreOf the estimated 10.4 million new tuberculosis cases globally in 2015, nearly 0.5 million estimated cases were multidrug-resistant (MDR) TB
Read More